J . Org. Chem. 2001, 66, 4413-4415
4413
Sch em e 1a
Ch em oselective Cycliza tion of
Am in on icotin ic Acid Der iva tives to
,8-Na p h th yr id in -2-on es via a P oten tia l
In tr a m olecu la r Aza d ien e-Keten e
Electr ocycliza tion Rea ction
1
Alexandros L. Zografos, Christos A. Mitsos, and
Olga Igglessi-Markopoulou*
National Technical University of Athens, Department of
Chemical Engineering, Laboratory of Organic Chemistry,
Zografou Campus, Athens 157 73, Greece
Received December 1, 2000
1
,8-Naphthyridinones are useful synthetic products
that were found to possess a variety of biological proper-
ties. Two classes of compounds, 1,8-naphthyridin-2-ones
and 1,8-naphthyridin-4-ones, have mainly attracted the
focus of the scientific community due to their unique
1
2
antibacterial, antiinflammatory, antiallergic, and anti-
secretory activities.3
3
-Substituted 1,8-naphthyridin-2-ones have been pre-
pared by treating substituted 2-aminonicotinic acid with
4
ethyl malonyl chloride or by reaction of 2-aminopyridines
5
with malonic esters. Similarly, the preparation of 2,3-
disubstituted 1,8-naphthyridin-4-ones was achieved by
cyclization of the appropriate substituted aminopyridine
derivatives.6
a
Key: (i) t-BuOK, THF.
One of the most common methods is that proposed by
Coppola, which involves reaction of aza-isatoic anhydride
with anions of â-keto esters. Although his method
appears to be general for the preparation of both 1,8-
naphthyridin-2-ones and 1,8-naphthyridin-4-ones, it pre-
sents disadvantages, such as the use of severe reaction
conditions and the formation of unequal amounts of both
products due to the intramolecular nucleophilic attack
of the aromatic amine on both the ester and ketone
carbonyl groups.7
attack by â-keto esters (2) under smooth reaction condi-
tions (Scheme 1).
Unexpectedly, the reaction of these activated systems
with nucleophiles does not give mixture of products in
contrast to Coppola’s method.
Thus, reaction of activated derivatives of aminonico-
tinic acid with 2 equiv of the appropriate â-ketoester
under basic solution of t-BuOK in THF gives only 2-alkyl-
3-alkoxycarbonyl 1,8-naphthyridin-4-one derivatives (4)
in good yields (Scheme 1).
7
In the course of our research on the synthesis of
heterocyclic systems comprising a â-dicarbonyl moiety,
we required a facile route to substituted 1,8-naphthyri-
dinones. To achieve the synthesis of 1,8-naphthyridin-
-ones, we have modified Coppola’s methodology by
Extending this method, we considered a versatile way
of preparing chemoselectively 1,8-naphthyridin-2-one
derivatives. The idea was to modify intermediate C-
acylation compound (I) in order to activate ester carbonyl
moiety.
8
4
making use of two new acylating agents, the N-succin-
imide ester of aminonicotinic acid (1) and azathio isatoic
anhydride (3). Both are excellent activating systems of
the carboxylic acid moiety and susceptible to nucleophilic
Thus, insertion of an electron-withdrawing group in
the amino functionality could give the desired activation
of ester group via a potential formation of a ketene
intermediate (II) (Figure 1).
Preparation of pyrido [2,3-d][3,1] oxazin-4-ones (5)
gives activation on the carboxylic acid moiety and the
desired protection for amino functionality. Reaction of 5
with anions of â-keto esters yields 1,8-naphthyridin-2-
ones (6) in a one-step route (Scheme 2). The protocol used
requires the reaction of 5 with 2 equiv of the anion of
the appropriate â-ketoester, generated with potassium
tert-butoxide. After acidification with 10% hydrochloric
acid, products of type 6 were obtained as pure solids.
The reaction is probably based on the formation of an
azadiene-ketene intermediate (IV), which is cyclized by
an intramolecular electrocyclization reaction. The deter-
minative factor in the formation of IV appears to be the
*
To whom correspondence should be addressed. Tel: +301 7723259,
301 7723074. Fax: +301 7723072.
1) Sherlock, M.; Kaminski, J .; Lee, T.; Wong, S.; Kreutner, W.;
Bryant, R.; McPhail, A. J . Med Chem. 1988, 31, 2108.
2) (a) Kuroda, T.; Suzuki, F. J . Heterocycl. Chem. 1991, 28, 2029.
b) Kuroda, T.; Suzuki, F. J . Med. Chem. 1992, 35, 1130.
3) Santilli, A.; Scotese, A.; Bauer, R.; Bell, S. J . Med. Chem. 1987,
0, 2270.
+
(
(
(
(
3
(
(
(
(
4) Paudler, W.; Kress, T. Adv. Heterocycl. Chem. 1970, 11, 123.
5) Schober, B.; Kappe, T. J . Heterocycl. Chem. 1988, 25, 1231.
6) Paudler, W.; Sheets, R. Adv. Heterocycl. Chem. 1983, 33, 147.
7) Coppola, G.; Fraser, J .; Hardtmann, G.; Shapiro, M. J . Heterocycl.
Chem. 1985, 22, 193.
8) Zografos, A.; Mitsos, C.; Igglessi-Markopoulou, O. Org. Lett. 1999,
, 1953. (b) Mitsos, C.; Zografos, A.; Igglessi-Markopoulou, O. J . Org.
Chem. 2000, 65, 5852.
(
1
1
0.1021/jo0057553 CCC: $20.00 © 2001 American Chemical Society
Published on Web 05/17/2001